DealBook – Another Big Windfall For JPMorgan In Drug Maker Deal – 18 February 2014

DealBook

By RACHEL ABRAMS

Actavis’s deal to acquire the drug maker Forest Laboratories means significant fees for JPMorgan Chase, the bank’s second apparent windfall in less than a week from advising on a big-ticket deal.

www.dealbook.nytimes.com / link to original article

Advertisements

Comments are closed.